Healio

Implementation of a nationwide tobacco cessation program could save more than 60,000 lives and $12 billion in healthcare costs in 10 years.A dynamic evaluation of the Tobacco Research and Treatment Program at The University of Texas MD Anderson Cancer Cen

Multiple human factors improved following revision of the packaging design and instructions for use on Anaphylm sublingual epinephrine film, according to topline results.As Healio previously reported, the FDA cited concerns about human factors in the use

In healthy young adults with normal spirometry, e-cigarette users and conventional cigarette smokers had similar poorer exercise capacity and vascular function vs. never vapers/smokers, according to findings published in ERJ Open Research."This work is th

The FDA granted priority review designation to a new drug application for tinlarebant, a potential treatment for Stargardt disease type 1, according to a press release from Belite Bio.

SCOTTSDALE, Ariz. - Contrary to guidelines, one in three eligible patients with new-onset diabetes do not receive a prescription for statin therapy within 1 year of diagnosis, a speaker reported.Many patients with new-onset diabetes aged 40 to 75 years wh

Polyendocrine metabolic ovarian syndrome was associated with increased risk for atherosclerotic cardiovascular disease events and the association was only partially mediated by the presence of baseline comorbidities, researchers reported.Polyendocrine met

Major topics of discussion at this year's American Society of Retina Specialists annual meeting included real-world data on the treatment of geographic atrophy in dry age-related macular degeneration."This was huge this year because now we actually have m

In this video, Vivienne S. Hau, MD, PhD, of Kaiser Permanente Bernard J. Tyson School of Medicine, discussed the emergence of oculomics, which was a topic at this year's American Society of Retina Specialists annual meeting.Hau explained the use of oculom

Sunir J. Garg, MD, FACS, FASRS, spoke about TH103, a novel biologic targeting both VEGF and heparan sulfate proteoglycans, in treatment-naive patients with wet age-related macular degeneration in this video interview.Results from the phase 1 single ascend